QUAY STEVEN C
SEC CIK 1008227 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATOS | ATOSSA THERAPEUTICS, INC. | Pres, CEO, Dir | 88.0K | $9,890 | — | 4 | 2025-05-21 | 2026-03-27 |
Most active insiders at ATOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Daniel Mark James | CFO | — | — |
| 2 | Cigler Tessa | Dir | — | — |
| 3 | Finn Jonathan | Dir | — | — |
| 4 | Chen Shu-Chih | Dir | — | — |
| 5 | Galli Stephen J | Dir | — | — |
| 6 | Remmel H. Lawrence | Dir | — | — |
| 7 | Steinhart Richard I | Dir | — | — |
| 8 | QUAY STEVEN C | Pres, CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-03-27 | ATOS | ATOSSA THERAPEUTICS, INC. | QUAY STEVEN C | Pres, CEO, Dir | A - Grant | $0.00 | +65.0K | 88.0K | +282% | $0 | |
| DA | 2026-01-30 | 2026-01-20 | ATOS | ATOSSA THERAPEUTICS, INC. | QUAY STEVEN C | Pres, CEO, Dir | A - Grant | $0.00 | +331.7K | 345.6K | +2,386% | $0 |
| D | 2026-01-22 | 2026-01-20 | ATOS | ATOSSA THERAPEUTICS, INC. | QUAY STEVEN C | Pres, CEO, Dir | A - Grant | $0.00 | +325.2K | 339.1K | +2,340% | $0 |
| 2025-05-22 | 2025-05-21 | ATOS | ATOSSA THERAPEUTICS, INC. | QUAY STEVEN C | Pres, CEO, Dir | P - Purchase | $0.88 | +11.2K | 13.9K | +423% | +$9,890 |
Purchase Sale Sale after option exercise All abbreviations